{"filing":{"accession_number":"0001683168-26-005850","cik":"0000882291","ticker":"AEMD","company_name":"AETHLON MEDICAL INC","form":"8-K","filing_date":"2026-07-31","report_date":"2026-07-30","primary_document":"aethlon_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316826005850/aethlon_8k.htm"},"events":[{"id":22905,"run_id":20741,"accession_number":"0001683168-26-005850","anchor_item_number":"3.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Aethlon Medical effectuated a 1-for-5 reverse stock split on July 30, 2026, reducing authorized shares from 100 million to 20 million and outstanding shares from approximately 3.25 million to approximately 650,000. The reverse split modifies the rights and structure of common stockholders and affects trading symbol adjustments and Nasdaq listing rule compliance.","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":23002,"accession_number":"0001683168-26-005850","item_number":"3.03","item_title":"Material Modification to Rights of Security","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure concerns a 1-for-5 reverse stock split effectuated via a Certificate of Change filed with Nevada's Secretary of State on July 30, 2026, under NRS Section 78.209. The filing modifies the rights and structure of common stock holders by reducing authorized shares from 100 million to 20 million and outstanding shares from approximately 3.25 million to approximately 650,000. While reverse stock splits are governance/capital structure events rather than a specific named type, this is material to investors as it affects share count, trading symbol adjustments, and compliance with Nasdaq listing rules—information that would influence investment decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:38:38.836371+00:00","company_name":"","ticker":null,"filing_date":""},{"id":23003,"accession_number":"0001683168-26-005850","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws;","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure concerns an amendment to the company's articles of incorporation or bylaws, specifically a change in fiscal year, as evidenced by the filing of a Certificate of Change. While fiscal year changes are governance matters, they are routine administrative adjustments that do not materially affect investor assessment of the registrant's financial condition or operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:38:38.836371+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23002,"accession_number":"0001683168-26-005850","item_number":"3.03","item_title":"Material Modification to Rights of Security","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure concerns a 1-for-5 reverse stock split effectuated via a Certificate of Change filed with Nevada's Secretary of State on July 30, 2026, under NRS Section 78.209. The filing modifies the rights and structure of common stock holders by reducing authorized shares from 100 million to 20 million and outstanding shares from approximately 3.25 million to approximately 650,000. While reverse stock splits are governance/capital structure events rather than a specific named type, this is material to investors as it affects share count, trading symbol adjustments, and compliance with Nasdaq listing rules—information that would influence investment decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:38:38.836371+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-07-31"},{"id":23003,"accession_number":"0001683168-26-005850","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws;","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure concerns an amendment to the company's articles of incorporation or bylaws, specifically a change in fiscal year, as evidenced by the filing of a Certificate of Change. While fiscal year changes are governance matters, they are routine administrative adjustments that do not materially affect investor assessment of the registrant's financial condition or operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:38:38.836371+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-07-31"}]}